Shilpa Medicare

Sector: Healthcare

Followers

5
5
6
6
.
1
1
3
3
3
3
-1.80 (-0.54%)

As on 05 Dec, 2025 | 15:59

Open Trading A/c
Day Range
330.00
336.00
LH
52 Week Range
277.50
500.00
LH
Volume
* i
Bid / Ask
102,130.00
0.00 / 0.00

Shilpa Medicare Announcements

Transcript

19 Nov, 2025 | 04:02pm • Source: BSE

Analyst/Investor Call -Call Recording

17 Nov, 2025 | 03:54pm • Source: BSE

Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)

17 Nov, 2025 | 10:36am • Source: NSE

Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)

17 Nov, 2025 | 10:25am • Source: BSE

Shilpa announces the launch of NODUCATM for the first time in India to treat metabolic dysfunction associated fatty liver disease (MAFLD)

17 Nov, 2025 | 10:25am • Source: BSE

Shilpa Medicare Limited has informed the Exchange regarding Board meeting held on November 13, 2025

13 Nov, 2025 | 03:06pm • Source:

Postal Ballot Results published in Newspaper

11 Nov, 2025 | 12:22pm • Source: BSE

Postal Ballot Results published in Newspaper

11 Nov, 2025 | 12:22pm • Source: BSE

Postal Ballot Results

10 Nov, 2025 | 03:17pm • Source: BSE

Shilpa Medicare Limited announces positive phase 3 results of OERIS(TM) -Ondansetron Extended - Release Injection for Chemotherapy - Induced Nausea and Vomiting (CINV).

10 Nov, 2025 | 12:42pm • Source: BSE

Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited, has been awarded the prestigious Gold Medal by EcoVadis, for Excellence in Sustainability

10 Nov, 2025 | 12:21pm • Source: NSE

Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited has been awarded the prestigious Gold Medal by EcoVadis for Excellence in Sustainability.

10 Nov, 2025 | 10:38am • Source: BSE

Schedule of Q2- FY26 Earnings Conference Call

05 Nov, 2025 | 05:44pm • Source: BSE

Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and...

05 Nov, 2025 | 04:42pm • Source: BSE

Shilpa Medicare Limited have signed definitive agreement to sell 31% stake in Sravathi Advance Process Technologies Pvt Ltd.

27 Oct, 2025 | 04:53pm • Source: BSE

The promoters of the Company have entered into an Inter-se Agreement on 16 October 2025

16 Oct, 2025 | 05:00pm • Source: BSE

Shilpa Medicare Limited has informed the Exchange about Certificate Under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018...

10 Oct, 2025 | 02:29pm • Source: NSE

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for Quarter ended 30 September, 2025.

10 Oct, 2025 | 01:24pm • Source: BSE

Postal Ballot Notice published in newspaper

09 Oct, 2025 | 12:31pm • Source: BSE

Postal Ballot Notice

07 Oct, 2025 | 06:19pm • Source: BSE